Sunil Kumar Dubey
Impact in
- Pharmaceutical Science top 0.05%
- Advancements in Transdermal Drug Delivery
- Advanced Drug Delivery Systems
- Dermatology top 0.5%
- Dermatology and Skin Diseases
Papers in
-
- RNA Interference and Gene Delivery 13
-
- Advancements in Transdermal Drug Delivery 22
- Advanced Drug Delivery Systems 20
- Co-authors
- Gautam Singhvi (67 shared papers)Tejashree Waghule (19 shared papers)Prashant Kesharwani (27 shared papers)Vamshi Krishna Rapalli (22 shared papers)Gaurav Gupta (7 shared papers)Kamal Dua (6 shared papers)Murali Monohar Pandey (4 shared papers)Amit Alexander (26 shared papers)
- Journals
- ACS Chemical Neuroscience (7 papers)Drug Discovery Today (6 papers)RSC Advances (5 papers)Journal of Controlled Release (5 papers)Biomedicine & Pharmacotherapy (5 papers)
- Partner nations
- IndiaUnited Arab EmiratesUnited States
In The Last Decade
Sunil Kumar Dubey
155 papers receiving 5.7k citations
Sunil Kumar Dubey's Hit Papers
Peers
Comparison fields: 5 of 163
- Pharmaceutical Science 2.1k
- Dermatology 747
- Biomaterials 972
- Molecular Medicine 281
- Drug Discovery 4
Countries citing papers authored by Sunil Kumar Dubey
This map shows the geographic impact of Sunil Kumar Dubey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sunil Kumar Dubey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sunil Kumar Dubey more than expected).
Fields of papers citing papers by Sunil Kumar Dubey
This network shows the impact of papers produced by Sunil Kumar Dubey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sunil Kumar Dubey. The network helps show where Sunil Kumar Dubey may publish in the future.
Co-authors
The 25 scholars most cited alongside Sunil Kumar Dubey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 159 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Microneedles: A smart approach and increasing potential for transdermal drug delivery system Hit paper breakdown → | 2018 | 952 |
| 2 | 2020 | 221 | |
| 3 | 2020 | 216 | |
| 4 | 2020 | 174 | |
| 5 | 2020 | 159 | |
| 6 | 2021 | 132 | |
| 7 | 2023 | 102 | |
| 8 | 2020 | 99 | |
| 9 | 2021 | 94 | |
| 10 | 2022 | 94 | |
| 11 | 2019 | 93 | |
| 12 | 2019 | 93 | |
| 13 | 2018 | 90 | |
| 14 | 2020 | 89 | |
| 15 | 2021 | 88 | |
| 16 | 2019 | 86 | |
| 17 | 2020 | 82 | |
| 18 | 2020 | 79 | |
| 19 | 2020 | 78 | |
| 20 | 2020 | 77 |
About Sunil Kumar Dubey
Sunil Kumar Dubey is a scholar working on Molecular Biology, Pharmaceutical Science, Biomaterials, Biomedical Engineering and Pharmacology, having authored 159 papers that have together received 5.9k indexed citations. Recurring topics across this work include Advancements in Transdermal Drug Delivery (22 papers), Advanced Drug Delivery Systems (20 papers), Nanoparticle-Based Drug Delivery (18 papers), RNA Interference and Gene Delivery (13 papers), Analytical Methods in Pharmaceuticals (12 papers), Analytical Chemistry and Chromatography (10 papers), Alzheimer's disease research and treatments (10 papers) and Nanoplatforms for cancer theranostics (10 papers). The work is most often cited by research in Pharmaceutical Science (2.1k citations), Dermatology (747 citations), Biomaterials (972 citations), Molecular Medicine (281 citations) and Drug Discovery (4 citations). Sunil Kumar Dubey has collaborated with scholars based in India, United Arab Emirates and United States. Frequent co-authors include Gautam Singhvi, Tejashree Waghule, Prashant Kesharwani, Vamshi Krishna Rapalli, Gaurav Gupta, Kamal Dua, Murali Monohar Pandey, Amit Alexander, Srividya Gorantla and Mahaveer Singh. Their work appears in journals such as ACS Chemical Neuroscience, Drug Discovery Today, RSC Advances, Journal of Controlled Release and Biomedicine & Pharmacotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.